Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perleux injectable hyaluronic acid gel for facial skin rejuvenation
IRCT20150101020514N17Phase 2Completed
- Sponsor
- Zist Orchid Pharmed
- Start
- Dec 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Perleux in cutaneous aging, sponsored by Zist Orchid Pharmed. Primary endpoint: Skin elasticity. Started Dec 2022; status: completed.
02
Drugs
Perleux
03
Conditions
cutaneous aging
Beyond the preview
Go deeper on IRCT20150101020514N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150101020514N17.